Abstract
Assessment of Healthcare Resource Utilization and Costs in Patients with Relapsed or Refractory Follicular Lymphoma Undergoing CAR-T Cell Therapy with Tisagenlecleucel: Results from the Elara Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have